Using Digital Storytelling and AI for Active Drug Safety Monitoring in Tuberculosis Care

Treatment for drug-resistant tuberculosis (DR-TB) is difficult and complex, and can cause side effects throughout the body. Active drug safety monitoring and management (aDSM) and pharmacovigilance (PV) — tools that help identify, report, and manage side effects — are critical to supporting the implementation of newer regimens. Innovations in TB support tools like AI companions and expressive writing and photography initiatives are filling gaps in care, and can help identify and manage treatment side effects.

TAG and KNCV are excited to present an upcoming webinar:

Using Digital Storytelling and AI for Active Drug Safety Monitoring in Tuberculosis Care

Date: Tuesday, June 30, 2026

Time: 9:00(EST)/15:00 (CET).

The webinar will cover:

In this webinar, KNCV staff will present cutting-edge technologies and artistic techniques that help people with TB express lived experiences and seek support during treatment. Specifically, KNCV will discuss Aida, a WhatsApp-based digital companion, and PhotoLetters to TB, a creative media initiative, to explore how digital tools and storytelling can enable community participation in active TB drug safety monitoring and management.

This is the latest installment in the series of virtual trainings for community and civil society organizations hosted by TAG under the Unitaid-funded ASCENT DR-TB Project.